Related Experiment Video
Updated: Jan 25, 2026

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
Published on: October 24, 2018
Extracorporeal Membrane Oxygenation Mortality in High-Risk Populations: An Analysis of the Pediatric Health
Ryan D Coleman1, Jordana Goldman1, Brady Moffett2
1From the Department of Pediatrics, Division of Critical Care Medicine, Baylor College of Medicine.
Insights
Extracorporporeal membrane oxygenation (ECMO) use in children has risen, but outcomes vary by condition. Bone marrow transplant, leukemia, and neutropenia significantly increase mortality risk in pediatric ECMO patients.
Area of Science:
- Pediatric critical care medicine
- Cardiovascular research
- Hematology/Oncology
Background:
- Extracorporporeal membrane oxygenation (ECMO) use in children is increasing.
- A growing number of pediatric patients with complex conditions are now ECMO candidates.
- The impact of specific underlying diseases on ECMO outcomes remains unclear.
Purpose of the Study:
- To evaluate the association between specific high-risk diagnoses and mortality in pediatric ECMO patients.
- To compare outcomes for children with complex congenital heart disease (CHD), malignancy, bone marrow transplant, or genetic abnormalities on ECMO.
Main Methods:
- Retrospective study using the Pediatric Health Information System database (2004-2013).
- Identified 9,194 pediatric ECMO cases.
- Compared outcomes of 2,200 "high-risk" patients (e.g., bone marrow transplant, leukemia, complex CHD) against overall ECMO population.
Main Results:
- Bone marrow transplant (81% mortality), leukemia (66% mortality), and neutropenia (58% mortality) were linked to significantly higher ECMO mortality.
- Complex CHD (52% mortality) and genetic syndromes (48% mortality) did not show increased mortality risk compared to the overall cohort.
- Odds ratios indicated increased mortality for bone marrow transplant (3.49), leukemia (1.88), and neutropenia (1.62).
Conclusions:
- Specific hematologic and oncologic conditions, such as bone marrow transplant and leukemia, are associated with substantially higher mortality in pediatric ECMO patients.
- Complex CHD and genetic syndromes, while serious, did not independently increase mortality risk in this pediatric ECMO cohort.
- Findings aid clinicians and families in risk-benefit assessments for ECMO candidacy in critically ill children with complex underlying conditions.
Abstract:
The number of children receiving extracorporeal membrane oxygenation (ECMO) has increased substantially, and includes a growing population of children with complex underlying conditions who previously may not have been considered ECMO candidates. However, it remains unclear to what extent the underlying disease impacts the risk of death in these patients, particularly related to malignancy, bone marrow transplantation, complex congenital heart disease (CHD), or chromosomal abnormalities. A retrospective study was performed using the Pediatric Health Information System database of all children placed on ECMO more than a 10 year period between 2004 and 2013. Patients with diagnoses of bone marrow transplant, leukemia, lymphoma, neutropenia, immune system abnormalities, genetic abnormalities, neoplastic disorders, and complex CHD were selected as "high risk" and their outcomes were compared with overall outcomes. Extracorporeal membrane oxygenation was used in 9,194 children. Two thousand two hundred (24%) were identified as high risk. Bone marrow transplant (81% mortality; odds ratio [OR] 3.49), leukemia (66% mortality; OR 1.88), and neutropenia (58% mortality; OR 1.62) were associated with higher odds of mortality. Complex CHD (52% mortality) and genetic syndromes (48%) were not associated with higher mortality. These findings are pertinent for clinicians and families when considering ECMO candidacy in these children.
Related Concept Videos
Conservation of Small Populations
Analysis of Population Pharmacokinetic Data
What is Population Genetics?
Population Growth
Relative Risk
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

